Utilización de marcadores tumorales séricos en cáncer colo-rectal, carcinoma hepatocelular, cáncer de mama y cáncer de pulmón (Informe nº: Osteba D-02-03)
- MeSH Terms
- Mass Screening (E01.370.500); Gastrointestinal Neoplasms (C04.588.274.476); Breast Neoplasms (C04.588.180); Lung Neoplasms (C04.588.894.797.520); Carcinoma; Hepatocellular (C04.588.274.623.160); alpha-Fetoproteins (D12.776.377.715.085.092); CA-125 Antigen (D23.050.285.050.225); CA-19-9 Antigen (D23.050.285.050.119); Carcinoembryonic Antigen (D23.050.301.350.210); Tissue Polypeptide Antigen (D23.050.285.840); Cohort Studies (E05.318.760.500.750); Sensitivity and Specificity (E05.318.740.872); Tumor Markers; Biological (D23.101.840)
- English Title Translation
- Tumour markers in certain cancer locations
- Publication Scope
- assessment
- management
- Countries of Application
- Spain
- Guideline Publication Status
- Published
- Languages
- Spanish
- Authors
- OSTEBA (ES)
- Publication Year
- 2002